Simvastatin
Simvastatin is a pharmaceutical drug with 326 clinical trials. Currently 9 active trials ongoing. Historical success rate of 89.9%.
Success Metrics
Based on 232 completed trials
Phase Distribution
Phase Distribution
85
Early Stage
65
Mid Stage
133
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
84.7%
232 of 274 finished
15.3%
42 ended early
9
trials recruiting
326
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
VISTA: Valproic Acid, Irinotecan, and Simvastatin for Recurrent Glioma
The Role of Bisphosphonate and Simvastatin Combination on Therapeutic Response in Breast Cancer With Bone Metastasis Via Dicckopf-1 Pathway
Simvastatin in Preventing Liver Cancer in Patients With Liver Cirrhosis
A Study of LY3526318 in Healthy Male Japanese Participants
Precision Medicine Adaptive Network Platform Trial in Hypoxemic Acute Respiratory Failure
Clinical Trials (326)
VISTA: Valproic Acid, Irinotecan, and Simvastatin for Recurrent Glioma
The Role of Bisphosphonate and Simvastatin Combination on Therapeutic Response in Breast Cancer With Bone Metastasis Via Dicckopf-1 Pathway
Simvastatin in Preventing Liver Cancer in Patients With Liver Cirrhosis
A Study of LY3526318 in Healthy Male Japanese Participants
Precision Medicine Adaptive Network Platform Trial in Hypoxemic Acute Respiratory Failure
Remedial Mechanism of Simvastatin and Ursodeoxycholic Acid in Liver Cirrhosis: Crosstalk of Bile Secretion, Gut Microbiome, and Host Immune Response
Simvastatin Treatment to Improve Patient-reported Outcomes in Patients With Chronic Pancreatitis
Letrozole With and Without Simvastatin for the Treatment of Stage I-III Hormone Receptor Positive, HER2 Negative Breast Cancer
RESTAGE (REpurposing STAtins to Improve Outcomes in GastroEsophageal Cancer) Trial
A Study of LY3502970 in Healthy Participants
Alveolar Ridge Splitting With Simvastatin/PRF Composite and Simultaneous Implant Placement
A Drug-Drug Interaction Study of Orforglipron (LY3502970) in Healthy Overweight and Obese Participants
Neurotoxicity Prophylaxis With Intrathecal Dexamethasone and Simvastatin Post Axi-Cel
Efficacy and Safety Study of MCI-196 Versus Simvastatin for Dyslipidaemia in Chronic Kidney Disease (CKD) Subjects on Dialysis
A Study to Investigate the Effect of MT-8554 on the Pharmacokinetics of Simvastatin and Rosuvastatin in Healthy Subjects
Study to Assess the Effect of AZD9291 on the Blood Levels of Simvastatin in Patients With EGFRm+ NSCLC
Phase IB Metformin, Digoxin, Simvastatin in Solid Tumors
A Study to Investigate the Effect of AZD5004 on Rosuvastatin, Atorvastatin, Simvastatin, Repaglinide and the Effect of Erythromycin on AZD5004 in Healthy Participants
Lipoprotein(a) Levels in Patients With Atherosclerotic Cardiovascular Diseases in Russia
Simvastatin in Secondary Progressive Multiple Sclerosis
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 326